Expansion of Umbilical Cord Blood Using a Unique Bio-system
Ex Vivo Expansion of Umbilical Cord Blood Using a Unique Bio-system
1 other identifier
observational
8
1 country
1
Brief Summary
By doing this study, researchers hope to develop a special technique and laboratory conditions to help support umbilical stem cell growth and multiplication. In this project, researchers propose a three dimensional (3D) microenvironment that mimics the bone marrow stem cell microenvironment, with its supporting cells of osteoblasts and stromal cells. In theory, this will result in better expansion of cord blood stem cells ex vivo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 2, 2010
CompletedFirst Posted
Study publicly available on registry
February 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedJanuary 3, 2013
December 1, 2012
9 months
February 2, 2010
December 28, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
bio-system for ex-vivo expansion of umbilical cord blood stem cells
To successfully expand the umbilical cord blood stem cells, a microenvironment that resembles the stem cell microenvironment, or stem cell 'niche' should be created. In designing this bio-system, we make use of several observations. Firstly, bone osteoblasts are important in promoting hematopoietic stem cell expansion , accordingly, this bio-system will ensure the physical proximity of the cord blood stem cells to a 3D bone tissue derived from mesenchymal stem cells (MSCs). These MSCs will be isolated from Wharton's jelly, and by using an osteogenic medium and special scaffolds, these MSCs will differentiate into osteogenic progenitors creating a 3D bone structure . The other observation is that, co-culture of cord blood stem cells with mesenchymal stem cells is superior to liquid cultures in terms of ex vivo expansion , accordingly, in this experiment, undifferentiated MSCs will be co-cultured with cord blood stem cells in the created 3D bone structure.
one year
Eligibility Criteria
umbilical cord collection from full-term caesarian section/normal vaginal delivery patients
You may qualify if:
- females that consent to permit researchers collect the discarded umbilical cords from the placenta and use for research purposes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Biospecimen
umbilical cord
Study Officials
- PRINCIPAL INVESTIGATOR
Omar Aljitawi, MD
University of Kansas Medical Center
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2010
First Posted
February 3, 2010
Study Start
February 1, 2010
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
January 3, 2013
Record last verified: 2012-12